Viva Biotech Holdings Balance Sheet Health
Financial Health criteria checks 3/6
Viva Biotech Holdings tiene unos fondos propios totales de CN¥3.6B y una deuda total de CN¥2.9B, lo que sitúa su ratio deuda/fondos propios en 78.9%. Sus activos y pasivos totales son CN¥8.1B y CN¥4.5B respectivamente. Viva Biotech Holdings El EBIT de la empresa es de CN¥290.1M, por lo que su ratio de cobertura de intereses es de 1.8. Su tesorería e inversiones a corto plazo ascienden a CN¥1.1B.
Key information
50.7%
Debt to equity ratio
CN¥1.87b
Debt
| Interest coverage ratio | 1.3x |
| Cash | CN¥1.04b |
| Equity | CN¥3.69b |
| Total liabilities | CN¥3.76b |
| Total assets | CN¥7.45b |
Recent financial health updates
Does Viva Biotech Holdings (HKG:1873) Have A Healthy Balance Sheet?
Jun 01
These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt In A Risky Way
Sep 25These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt Extensively
Apr 14Is Viva Biotech Holdings (HKG:1873) Using Too Much Debt?
Nov 06We Think Viva Biotech Holdings (HKG:1873) Is Taking Some Risk With Its Debt
Apr 17Recent updates
Positive Sentiment Still Eludes Viva Biotech Holdings (HKG:1873) Following 27% Share Price Slump
Jan 19Does Viva Biotech Holdings (HKG:1873) Have A Healthy Balance Sheet?
Jun 01These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt In A Risky Way
Sep 25Is It Too Late To Consider Buying Viva Biotech Holdings (HKG:1873)?
Jul 11These 4 Measures Indicate That Viva Biotech Holdings (HKG:1873) Is Using Debt Extensively
Apr 14Is Now The Time To Look At Buying Viva Biotech Holdings (HKG:1873)?
Dec 23Is Viva Biotech Holdings (HKG:1873) Using Too Much Debt?
Nov 06Estimating The Intrinsic Value Of Viva Biotech Holdings (HKG:1873)
Jun 13We Think Viva Biotech Holdings (HKG:1873) Is Taking Some Risk With Its Debt
Apr 17Viva Biotech Holdings (HKG:1873) Shareholders Have Enjoyed A 55% Share Price Gain
Mar 13Need To Know: Viva Biotech Holdings (HKG:1873) Insiders Have Been Selling Shares
Feb 06What Percentage Of Viva Biotech Holdings (HKG:1873) Shares Do Insiders Own?
Jan 02Can You Imagine How Viva Biotech Holdings' (HKG:1873) Shareholders Feel About The 65% Share Price Increase?
Nov 21
Financial Position Analysis
Pasivos a corto plazo: 1873Los activos a corto plazo (CN¥2.0B) de la empresa superan a sus pasivos a corto plazo (CN¥1.5B).
Pasivo a largo plazo: Los activos a corto plazo de 1873 (CN¥2.0B) no cubren sus pasivos a largo plazo (CN¥2.2B).
Debt to Equity History and Analysis
Nivel de deuda: 1873(22.6%) se considera satisfactoria.
Reducción de la deuda: 1873 ha pasado de 88.7% a 50.7% en los últimos 5 años.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Cash runway estable: Datos insuficientes para determinar si 1873 tiene suficiente margen de liquidez basado en su flujo de caja libre actual.
Pronóstico de cash runway: Datos insuficientes para determinar si 1873 tiene suficiente margen de liquidez en caso de que su flujo de caja libre siga creciendo o disminuyendo en función de las tasas históricas.